Mio Yanagisawa
Surgery · Fayetteville, GANPI 1376955831
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 57 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by Merck at 35.4% of the total. Reporting peaked in 2023 at $417 and has fallen 51.5% since, to $202 in 2025. That places this record below the midpoint for surgery clinicians in GA, where the typical reported total is $1,913.
Across 57 payments — averaging $22.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$463
- AstraZeneca$134
- Seagen Inc.$101
- Molli Surgical (US) Inc$72
- Intuitive Surgical$64
- Stryker$64
- plus $410 from 14 others
What the payments were for
- Food & beverage$1,308100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 19 | $463 |
| AstraZeneca | 6 | $134 |
| Seagen Inc. | 5 | $101 |
| Molli Surgical (US) Inc | 1 | $72 |
| Intuitive Surgical | 1 | $64 |
| Stryker | 2 | $64 |
| Elucent Medical | 3 | $51 |
| Solventum Corporation | 2 | $49 |
| Integra Lifesciences Corporation | 2 | $47 |
| Vertex | 2 | $38 |
| Johnson & Johnson | 2 | $34 |
| Tactile Systems Technology Inc | 2 | $33 |
| Hologic Sales And Service, LLC | 2 | $31 |
| Nabriva Therapeutics, PLC | 2 | $28 |
| Pacira Pharmaceuticals Incorporated | 1 | $23 |
| LSI Solutions Inc | 1 | $16 |
| Myriad Genetic Laboratories, Inc. | 1 | $16 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $16 |
| Baxter Healthcare | 1 | $14 |
| Dilon Technologies, Inc. | 1 | $14 |
How this compares
$1,308 in reported general payments places this provider in the 40th percentile of 855 surgery providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 45 | $206 |
| Ondansetron OdtOndansetron | 15 | $142 |
| Methocarbamol | 22 | $98 |
| Ibuprofen | 29 | $74 |
| Tramadol Hcl | 37 | $65 |
Paid to pharmacies, not to this prescriber.
Other surgery in Fayetteville
- Russell WilsonFayetteville$25K
- Chad CopperGainesville$999K
- Zachary KlaassenAugusta$763K
- Stephen OdomAustell$599K
- Fritz Jean-PierreMarietta$464K
- Kendra GrubbAtlanta$374K
- Harry LightfootSmyrna$241K
- Oliver WhippleSavannah$222K
- Nelson RoyallGainesville$220K
- Ankit PatelAtlanta$217K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.